Matthew Watson
Company: Merck & Co
Job title: Principal Scientist
Seminars:
Chair’s Closing Remarks 3:40 pm
day: Conference Day Two
Roundtable Discussion: Optimizing Analytical Development to Create a Toolkit for De-Risking Critical Stages in Plasmid DNA Production 1:40 pm
How to develop fit-for-use analytics to enable comprehensive plasmid characterization and assessing suitability for downstream therapeutic applications How to implement a targeted testing approach to minimize redundancy and streamline the plasmid development process by focusing on critical checkpoints How can we tailor analytical testing to enable consistent quality for both off-the-shelf and personalized plasmids?Read more
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day Two
Maximizing the Recovery of Plasmid DNA: Accelerating Workflow to Increase the Efficiency of Lysis & DNA Extraction 3:45 pm
Developing efficient lysis procedures tailored to plasmid DNA extraction to reduce genomic DNA contamination Controlling important parameters to reduce shearing stress on plasmid DNA and promote a high yield of unbroken plasmids Closely monitoring parameters such as pH, buffer choice, and salt concentrations to prepare the extract for purificationRead more
day: Conference Day One